Fulgent Genetics (FLGT) Total Non-Current Liabilities (2016 - 2026)

Fulgent Genetics (FLGT) has 11 years of Total Non-Current Liabilities data on file, last reported at $102.8 million in Q1 2026.

• Quarterly Total Non-Current Liabilities rose 33.82% year-over-year to $102.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $102.8 million (up 33.82% YoY) and the FY2025 annual result came in at $99.2 million, up 9.66% from the prior year.
• Total Non-Current Liabilities advanced to $102.8 million in Q1 2026 per FLGT's latest filing, from $99.2 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $149.2 million in Q2 2022, with the low at $74.7 million in Q2 2023.
• Average Total Non-Current Liabilities over 5 years is $98.9 million, with a median of $97.3 million recorded in 2024.
• Year-over-year, Total Non-Current Liabilities slumped 49.96% in 2023 and jumped 33.82% in 2026.
• Fulgent Genetics' Total Non-Current Liabilities stood at $97.9 million in 2022, then fell by 1.92% to $96.1 million in 2023, then dropped by 5.85% to $90.4 million in 2024, then grew by 9.66% to $99.2 million in 2025, then advanced by 3.69% to $102.8 million in 2026.
• Business Quant data shows FLGT's Total Non-Current Liabilities at $102.8 million in Q1 2026, $99.2 million in Q4 2025, and $91.8 million in Q3 2025.